NFKB1 and carcinoma: Collectively, these findings indicate that Ykiact tumors activate NF-κB signaling within the gut, a phenomenon that mirrors observations in several human carcinomas where the upregulation of the NF-κB pathway creates a supportive microenvironment critical for tumor initiation and progression61.